| M J BurkeAffiliation: University of Kansas Medical Center Country: USA Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practiceM J Burke Department of Psychiatry and Behavioural Sciences, University of Kansas School of Medicine, Wichita 67214, USA Clin Pharmacokinet 37:147-65. 1999 Trends in undergraduate medical education: clinical clerkship learning objectivesMichael J Burke University of Kansas School of Medicine, Department of Psychiatry and Behavioral Sciences, 1010 N Kansas, Wichita, KS 67214, USA Acad Psychiatry 30:158-65. 2006 Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depressionMichael J Burke Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine, Wichita, KS J ECT 22:218-22. 2006 Implementing a systematic course/clerkship peer review processMichael J Burke Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine, Witchita, 67214, USA Acad Med 77:930-1. 2002 Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastomaMichael J Burke Division of Hematology Oncology Transplant, Children s Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA Pediatr Blood Cancer 50:679-80. 2008 Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumorsMichael J Burke Division of Hematology, Children s Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60614 3394, USA Pediatr Blood Cancer 49:196-8. 2007
| |